HomeNews

News

  • Brain antioxidant levels can detect progression of Alzheimer’s Disease, study states

    • October 14, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • FDA approves Galcanezumab (Emgality) for Preventive Migraine Treatment

    • October 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Smartphones can be used to detect Parkinson’s symptoms early, research says

    • October 8, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Samumed And United Therapeutics enter Agreement For Ph I IPF Drug

    • September 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Teva Announces AJOVY™ (fremanezumab) approval in the US market

    • September 17, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Further evidence generated for Neurofilament light chain as MS biomarker

    • September 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Xenon includes Phase 3 Ready molecule in pipeline for Epilepsy

    • September 7, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Ibudilast shows benefits on slowing brain shrinkage in the latest trial results

    • September 6, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Roivant acquires therapy to treat Chronic Cough in IPF patients

    • September 6, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more

  • Novel Biomarker for diagnosis of Alzheimer’s identified by researchers

    • September 5, 2018
    • Posted by: PharmaScroll
    • Category:
    No Comments
    read more